SAINT HELIER (dpa-AFX) - Shire plc (SHP.L, SHPG) announced the successful completion of the tender offer for all of the outstanding shares of NPS Pharmaceuticals, Inc. (NPSP) and the subsequent acquisition of NPS Pharma. As of the expiration of the tender offer on February 20, a total of approximately 88,869,118 common shares of NPS Pharma had been validly tendered and not withdrawn pursuant to the tender offer, representing approximately 81.7% of the outstanding common shares of NPS Pharma.
NPS Pharma became a wholly owned subsidiary of Shire and NPS Pharma's shares ceased to be traded on NASDAQ.
Copyright RTT News/dpa-AFX
© 2015 AFX News
